Skip to content

Movement patterns in rheumatic and musculoskeletal diseases

Movement patterns in rheumatic and musculoskeletal diseases - BeMuGa

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033076
Enrollment
800
Registered
2024-02-28
Start date
2020-11-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M00-M99

Interventions

Group 1: Inquire if patients with different rheumatic diseases show gait parameters that are typical for the disease and which of those parameters fit for depicting disease activity. Inquire if and h

Sponsors

Universitätsklinikum Erlangen, Medizinische Klinik 3 - Rheumatologie & Immunologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with a diagnosis of inflammatory rheumatic diseases (e.g. rheumatoid arthritis, spondyloarthritis (psoriatic arthritis, axial spondyloarthritis), myositis, scleroderma, vasculitis) - Patients with an increased risk of developing an inflammatory rheumatic disease (psoriasis, anti-CCP positive patients (preRA)) - Patients with degenerative joint diseases (osteoarthritis of the knee) and - healthy controls - Patients must be able to walk a specified distance (4 x 10 metres) or walking time (up to 2 minutes) independently, without assistance. - Age = 18 years - Written consent to study participation and data protection

Exclusion criteria

Exclusion criteria: - surgical interventions or osteoarthritis of the lower limbs, spinal disc herniation or other factors that could influence gait - Patients who are dependent on walking aids, wheelchairs or assistance when walking.

Design outcomes

Primary

MeasureTime frame
Space-time parameters of walking (double step duration, double step length, cadence, number of steps, gait speed), ankle, knee and hip joint angles, walking distance (2 min walk test), physical activity (IPAQ), diagnosis

Secondary

MeasureTime frame
Association of primary outcome measures with clinical routine and corresponding rheumatic disease (e.g. DAS-28, PSAID, RAID, MASES, BASMI, BASDAI, routine laboratory parameters, joint status) as well as patient well-being (e.g. SF-36, HAQ), physical activity-related health literacy (PAHCO), chronic pain of neuropathic origin (PainDetect) and fear of pain (TSK). In addition, past fractures, smoking status, menopausal status in women, medical history and dietary habits that could affect bone/cartilage health (injuries, medications, supplements).

Countries

Germany

Contacts

Public ContactAnna-Maria Liphardt

Universitätsklinikum Erlangen, Medizinische Klinik 3 - Rheumatologie & Immunologie

Anna-Maria.Liphardt@uk-erlangen.de091318543206

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026